VANGUARD HEALTH SYSTEMS INC EBITDA

2013-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $60.70M.
2012-12-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $67.80M.
2012-09-30: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $65.60M.
2012-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $62.90M.

Historical EBITDA

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2013-03-31	Reported	(m)	(m)	$60.70M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$12.40M
2012-12-31	Reported	(m)	(m)	$67.80M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$7.20M
2012-09-30	Reported	(m)	(m)	$65.60M	(m)	(m)	$82.70M	-$56.40M	(m)	(m)	(m)	$4.90M
2012-03-31	Reported	(m)	(m)	$62.90M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$24.30M
2011-12-31	Reported	(m)	(m)	$65.80M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$11.30M
2011-09-30	Reported	(m)	(m)	$62.60M	(m)	(m)	$63.40M	-$87.80M	(m)	(m)	(m)	-$15.20M
2011-03-31	Reported	(m)	(m)	$55.80M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$4.40M
2010-12-31	Reported	(m)	(m)	$38.60M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$9.70M
2010-09-30	Reported	(m)	(m)	$37.20M	(m)	(m)	$44.60M	$100.20M	(m)	(m)	(m)	-$2.40M

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2013-06-30	Reported	(m)	(m)	$257.10M	(m)	(m)	$420.50M	$300.80M	(m)	(m)	(m)	$40.80M
2012-06-30	Reported	(m)	(m)	$258.30M	(m)	(m)	$293.30M	$113.60M	(m)	(m)	(m)	$22.20M
2011-06-30	Reported	(m)	(m)	$193.80M	(m)	(m)	$206.50M	$276.60M	(m)	(m)	(m)	$8.60M
2010-06-30	Reported	(m)	(m)	$139.60M	(m)	(m)	$155.90M	$315.20M	(m)	(m)	(m)	-$13.80M